MNOW — Mednow Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -375.56% | ||
| Operating Margin | -60.55% | ||
Financial Summary
| Year End 31st Jul | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | 0.41 | 16.64 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Mednow Inc. is a Canada-based healthcare technology company, which offers virtual access with a high standard of care. The Company provides virtual pharmacy and telemedicine services, as well as doctor home visits through an interdisciplinary approach to healthcare that is focused on the patient experience. The Company’s services include free at-home delivery of medications, doctor consultations, a user-friendly interface for easy upload, transfer, and refill of prescriptions, access to healthcare professionals through an intuitive chat experience and the specialized PillSmart system that packages prescriptions in easy-to-use daily dose packs, each labelled with the date and time of the next dose. It delivers vital prescription medications all across Canada. PillSmart is its medication management solution that simplifies the process of taking their medication. Its medication management program provides members with 1:1 care and the support needed to get the out of their medication.
Directors
- Last Annual
- July 31st, 2022
- Last Interim
- April 30th, 2023
- Incorporated
- January 17th, 2018
- Public Since
- March 9th, 2021
- No. of Employees
- 60
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 25,864,377
- Address
- 4484 Main Street, VANCOUVER, V3V 5R5
- Web
- https://mednow.ca/
- Phone
- +1 4168277800
- Auditors
- MNP LLP
Upcoming Events for MNOW
Similar to MNOW
Astron Connect
TSX Venture Exchange
CanadaBis Capital
TSX Venture Exchange
DavidsTea
TSX Venture Exchange
High Tide
TSX Venture Exchange
Rocky Mountain Liquor
TSX Venture Exchange
FAQ
As of Today at 18:14 UTC, shares in Mednow are trading at CA$0.02. This share price information is delayed by 15 minutes.
Shares in Mednow last closed at CA$0.02 and the price had moved by -83.82% over the past 365 days. In terms of relative price strength the Mednow share price has underperformed the Toronto Stock Exchange 300 Composite Index by -84.13% over the past year.
There is no consensus recommendation for this security.
Mednow does not currently pay a dividend.
Mednow does not currently pay a dividend.
Mednow does not currently pay a dividend.
To buy shares in Mednow you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.02, shares in Mednow had a market capitalisation of .
Here are the trading details for Mednow:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: MNOW
Based on an overall assessment of its quality, value and momentum Mednow is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mednow. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -86.02%.
As of the last closing price of CA$0.02, shares in Mednow were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Mednow PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Mednow's directors